Kathryn King - Aptinyx VP Operations
Insider
Kathryn King is VP Operations of Aptinyx
Phone | 847 871 0377 |
Web | https://www.aptinyx.com |
Aptinyx Management Efficiency
The company has return on total asset (ROA) of (0.5135) % which means that it has lost $0.5135 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3806) %, meaning that it created substantial loss on money invested by shareholders. Aptinyx's management efficiency ratios could be used to measure how well Aptinyx manages its routine affairs as well as how well it operates its assets and liabilities.Aptinyx currently holds 22.11 M in liabilities with Debt to Equity (D/E) ratio of 0.39, which is about average as compared to similar companies. Aptinyx has a current ratio of 15.9, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Aptinyx's use of debt, we should always consider it together with its cash and equity.
Similar Executives
Showing other executives | INSIDER Age | ||
Eugene Jiang | ABVC Biopharma | 39 | |
Satyavrat CFA | Spero Therapeutics | 52 | |
Robert Bazemore | Nuvation Bio | 53 | |
CPA CPA | Aditxt Inc | 56 | |
Robert Dudley | Transcode Therapeutics | 73 | |
MBA MBA | Adial Pharmaceuticals | 47 | |
Stacy Markel | Nuvation Bio | 60 | |
BSc FRCPath | Achilles Therapeutics PLC | 59 | |
Tharaknath Rao | Assembly Biosciences | N/A | |
Kathryn Falberg | Nuvation Bio | 60 | |
Lawrence CPA | Adial Pharmaceuticals | 68 | |
Iraj Ali | Achilles Therapeutics PLC | 50 | |
Christopher Ogden | CytomX Therapeutics | 41 | |
TsungShann Jiang | ABVC Biopharma | 70 | |
Michael Myers | Quoin Pharmaceuticals Ltd | 63 | |
Hoyoung MD | CytomX Therapeutics | 56 | |
Matthew Shatzkes | Aditxt Inc | N/A | |
Rowena Albanna | Aditxt Inc | 59 | |
Qiyong Liu | Transcode Therapeutics | 60 | |
Mark Dudley | Instil Bio | N/A | |
Jamie Moore | CytomX Therapeutics | N/A |
Management Performance
Return On Equity | -1.38 | |||
Return On Asset | -0.51 |
Aptinyx Leadership Team
Elected by the shareholders, the Aptinyx's board of directors comprises two types of representatives: Aptinyx inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aptinyx. The board's role is to monitor Aptinyx's management team and ensure that shareholders' interests are well served. Aptinyx's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aptinyx's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kathryn King, VP Operations | ||
Norbert Riedel, President CEO, Director | ||
Patrick Flavin, Sr Relations | ||
Molly Dir, VP HR | ||
Ashish Khanna, Chief Business Officer | ||
Harald MD, VP Affairs | ||
Tim Noffke, VP Staff | ||
MD BCh, Pres CEO |
Aptinyx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aptinyx a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -1.38 | |||
Return On Asset | -0.51 | |||
Current Valuation | (25.91 M) | |||
Shares Outstanding | 67.72 M | |||
Shares Owned By Insiders | 13.12 % | |||
Shares Owned By Institutions | 42.96 % | |||
Number Of Shares Shorted | 2.23 M | |||
Price To Earning | (5.61) X | |||
Price To Book | 0.33 X | |||
Price To Sales | 45.33 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Aptinyx Stock
If you are still planning to invest in Aptinyx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptinyx's history and understand the potential risks before investing.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Stocks Directory Find actively traded stocks across global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |